{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:37:32Z","timestamp":1790771852955,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T00:00:00Z","timestamp":1466121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006014","name":"College of Medicine and Health Sciences, United Arab Emirates University","doi-asserted-by":"publisher","award":["31M123"],"award-info":[{"award-number":["31M123"]}],"id":[{"id":"10.13039\/501100006014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s11010-016-2733-y","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T12:13:38Z","timestamp":1466165618000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":159,"title":["\u03b2-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease"],"prefix":"10.1007","volume":"418","author":[{"given":"Shreesh","family":"Ojha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayate","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Azimullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Emdadul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,17]]},"reference":[{"issue":"6","key":"2733_CR1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/JNN.0000000000000162","volume":"47","author":"A Gopalakrishna","year":"2015","unstructured":"Gopalakrishna A, Alexander SA (2015) Understanding Parkinson disease: a complex and multifaceted illness. J Neurosci Nurs 47(6):320\u2013326","journal-title":"J Neurosci Nurs"},{"key":"2733_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"CW Olanow","year":"1999","unstructured":"Olanow\u00a0CW,\u00a0Tatton WG (1999) Etiology and pathogenesis of\u00a0Parkinson's disease. Annu Rev Neurosci 22:123\u2013144 \u00a0","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"2733_CR3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","volume":"49","author":"R Niranjan","year":"2014","unstructured":"Niranjan R (2014) The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes. Mol Neurobiol 49(1):28\u201338","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2733_CR4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","volume":"62","author":"JM Taylor","year":"2013","unstructured":"Taylor JM, Main BS, Crack PJ (2013) Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u2019s disease. Neurochem Int 62(5):803\u2013819","journal-title":"Neurochem Int"},{"issue":"1","key":"2733_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13311-013-0218-1","volume":"11","author":"A Al Dakheel","year":"2014","unstructured":"Al Dakheel A, Kalia LV, Lang AE (2014) Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics 11(1):6\u201323","journal-title":"Neurotherapeutics"},{"issue":"8","key":"2733_CR6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbadis.2013.09.007","volume":"1842","author":"H Jin","year":"2014","unstructured":"Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG (2014) Mitochondria-targeted antioxidants for treatment of Parkinson\u2019s disease: preclinical and clinical outcomes. Biochim Biophys Acta 1842(8):1282\u20131294","journal-title":"Biochim Biophys Acta"},{"key":"2733_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnagi.2014.00036","volume":"6","author":"SE Seidl","year":"2014","unstructured":"Seidl SE, Santiago JA, Bilyk H, Potashkin JA (2014) The emerging role of nutrition in Parkinson\u2019s disease. Front Aging Neurosci 6:36","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2733_CR8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jep.2011.12.030","volume":"139","author":"JX Song","year":"2012","unstructured":"Song JX, Sze SC, Ng TB, Lee CK, Leung GP, Shaw PC, Tong Y, Zhang YB (2012) Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? J Ethnopharmacol 139(3):698\u2013711","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"2733_CR9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/187221412802481793","volume":"6","author":"RB Mythri","year":"2012","unstructured":"Mythri RB, Harish G, Bharath MM (2012) Therapeutic potential of natural products in Parkinson\u2019s disease. Recent Pat Endocr Metab Immune Drug Discov 6(3):181\u2013200","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"issue":"1","key":"2733_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2011.09.002","volume":"133","author":"AJ Hill","year":"2012","unstructured":"Hill AJ, Williams CM, Whalley BJ, Stephens GJ (2012) Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther 133(1):79\u201397","journal-title":"Pharmacol Ther"},{"issue":"7","key":"2733_CR11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2174\/138955711795906905","volume":"11","author":"JP Little","year":"2011","unstructured":"Little JP, Villanueva EB, Klegeris A (2011) Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson\u2019s disease. Mini Rev Med Chem 11(7):582\u2013590","journal-title":"Mini Rev Med Chem"},{"issue":"26","key":"2733_CR12","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"105","author":"J Gertsch","year":"2008","unstructured":"Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A (2008) Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 105(26):9099\u20139104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2733_CR13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.lfs.2006.11.009","volume":"80","author":"HJ Chang","year":"2007","unstructured":"Chang HJ, Kim HJ, Chun HS (2007) Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids. Life Sci 80(9):835\u2013841","journal-title":"Life Sci"},{"issue":"1\u20133","key":"2733_CR14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2013.01.011","volume":"702","author":"MA Abbas","year":"2013","unstructured":"Abbas MA, Taha MO, Zihlif MA, Disi AM (2013) \u03b2-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility. Eur J Pharmacol 702(1\u20133):12\u201319","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2733_CR15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","volume":"178","author":"AF Bento","year":"2011","unstructured":"Bento AF, Marcon R, Dutra RC, Claudino RF, Cola M, Leite DF, Calixto JB (2011) \u03b2-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPAR\u03b3 pathway. Am J Pathol 178(3):1153\u20131166","journal-title":"Am J Pathol"},{"key":"2733_CR16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejphar.2015.08.001","volume":"764","author":"HI Cho","year":"2015","unstructured":"Cho HI, Hong JM, Choi JW, Choi HS, Hwan Kwak J, Lee DU, Kook Lee S, Lee SM (2015) \u03b2-Caryophyllene alleviates d-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways. Eur J Pharmacol 764:613\u2013621","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2733_CR17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2013.05.108","volume":"436","author":"X Zheng","year":"2013","unstructured":"Zheng X, Sun T, Wang X (2013) Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1\/PGC-1\u03b1 pathway. Biochem Biophys Res Commun 436(3):377\u2013381","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2733_CR18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","volume":"182","author":"IY Choi","year":"2013","unstructured":"Choi IY, Ju C, Anthony Jalin AM, da Lee I, Prather PL, Kim WK (2013) Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury. Am J Pathol 182(3):928\u2013939","journal-title":"Am J Pathol"},{"issue":"1","key":"2733_CR19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11064-014-1474-0","volume":"40","author":"H Liu","year":"2015","unstructured":"Liu H, Song Z, Liao D, Zhang T, Liu F, Zhuang K, Luo K, Yang L (2015) Neuroprotective effects of trans-caryophyllene against kainic acid induced seizure activity and oxidative stress in mice. Neurochem Res 40(1):118\u2013123","journal-title":"Neurochem Res"},{"issue":"1","key":"2733_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12031-014-0243-5","volume":"54","author":"K Guo","year":"2014","unstructured":"Guo K, Mou X, Huang J, Xiong N, Li H (2014) Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-\u03baB activation in microglia. J Mol Neurosci 54(1):41\u201348","journal-title":"J Mol Neurosci"},{"issue":"1\u20132","key":"2733_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000362689","volume":"94","author":"Y Cheng","year":"2014","unstructured":"Cheng Y, Dong Z, Liu S (2014) \u03b2-Caryophyllene ameliorates the Alzheimer-like phenotype in APP\/PS1 Mice through CB2 receptor activation and the PPAR\u03b3 pathway. Pharmacology 94(1\u20132):1\u201312","journal-title":"Pharmacology"},{"key":"2733_CR22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2014.06.025","volume":"124","author":"S Al Mansouri","year":"2014","unstructured":"Al Mansouri S, Ojha S, Al Maamari E, Al Ameri M, Nurulain SM, Bahi A (2014) The cannabinoid receptor 2 agonist, \u03b2-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice. Pharmacol Biochem Behav 124:260\u2013268","journal-title":"Pharmacol Biochem Behav"},{"key":"2733_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuroscience.2014.08.043","volume":"279","author":"LC Assis","year":"2014","unstructured":"Assis LC, Straliotto MR, Engel D, Hort MA, Dutra RC, de Bem AF (2014) \u03b2-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway. Neuroscience 279:220\u2013231","journal-title":"Neuroscience"},{"issue":"6","key":"2733_CR24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14(6):724\u2013738","journal-title":"Cell Metab"},{"issue":"2","key":"2733_CR25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34(2):279\u2013290","journal-title":"Neurobiol Dis"},{"key":"2733_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1248\/bpb.28.169","volume":"28","author":"T Fujikawa","year":"2005","unstructured":"Fujikawa T, Kanada N, Shimada A, Ogata M, Suzuki I, Hayashi I, Nakashima K (2005) Effect of sesamin in Acanthopanax senticosus HARMS on behavioral dysfunction in rotenone-induced Parkinsonian rats. Biol Pharm Bull 28:169\u2013172","journal-title":"Biol Pharm Bull"},{"key":"2733_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","volume":"341","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Kim JH, Greenamyre JT (2003) Selective microglial activation in the rat rotenone model of Parkinson\u2019s disease. Neurosci Lett 341:87\u201390","journal-title":"Neurosci Lett"},{"key":"2733_CR28","first-page":"5499","volume":"9","author":"S Ojha","year":"2015","unstructured":"Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME (2015) Neuroprotective potential of ferulic acid in the rotenone model of Parkinson\u2019s disease. Drug Des Dev Ther 9:5499\u20135510","journal-title":"Drug Des Dev Ther"},{"key":"2733_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.32604\/biocell.2013.37.017","volume":"37","author":"M Messripour","year":"2013","unstructured":"Messripour M, Messripour A (2013) Age related interaction of dopamine and serotonin synthesis in striatal synaptosomes. Biocell 37:17\u201321","journal-title":"Biocell"},{"key":"2733_CR30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fphys.2013.00242","volume":"4","author":"S Pizzimenti","year":"2013","unstructured":"Pizzimenti S, Ciamporcero E, Daga M, Pettazzoni P, Arcaro A, Cetrangolo G, Minelli R, Dianzani C, Lepore A, Gentile F, Barrera G (2013) Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Front Physiol 4:242","journal-title":"Front Physiol"},{"key":"2733_CR31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neuroscience.2012.11.006","volume":"231","author":"P Thakur","year":"2013","unstructured":"Thakur P, Nehru B (2013) Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson\u2019s disease. Neuroscience 231:420\u2013431","journal-title":"Neuroscience"},{"issue":"3","key":"2733_CR32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","volume":"15","author":"JJ Sutachan","year":"2012","unstructured":"Sutachan JJ, Casas Z, Albarracin SL, Stab BR, Samudio I, Gonzalez J, Morales L, Barreto GE (2012) Cellular and molecular mechanisms of antioxidants in Parkinson\u2019s disease. Nutr Neurosci 15(3):120\u2013126","journal-title":"Nutr Neurosci"},{"issue":"1","key":"2733_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1476830511Y.0000000028","volume":"15","author":"SL Albarracin","year":"2012","unstructured":"Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, Gonzalo L, Capani F, Morales L, Barreto GE (2012) Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci 15(1):1\u20139","journal-title":"Nutr Neurosci"},{"key":"2733_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","volume":"62","author":"M Smeyne","year":"2013","unstructured":"Smeyne M, Smeyne RJ (2013) Glutathione metabolism and Parkinson\u2019s disease. Free Radic Biol Med 62:13\u201325","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"2733_CR35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S0007114512001298","volume":"109","author":"MA Calleja","year":"2013","unstructured":"Calleja MA, Vieites JM, Montero-Mel\u00e9ndez T, Torres MI, Faus MJ, Gil A, Su\u00e1rez A (2013) The antioxidant effect of \u03b2-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation. Br J Nutr 109(3):394\u2013401","journal-title":"Br J Nutr"},{"issue":"6","key":"2733_CR36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2131\/jts.39.849","volume":"39","author":"I Alvarez-Gonz\u00e1lez","year":"2014","unstructured":"Alvarez-Gonz\u00e1lez I, Madrigal-Bujaidar E, Castro-Garc\u00eda S (2014) Antigenotoxic capacity of beta-caryophyllene in mouse, and evaluation of its antioxidant and GST induction activities. J Toxicol Sci 39(6):849\u2013859","journal-title":"J Toxicol Sci"},{"issue":"7","key":"2733_CR37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.6026\/97320630008319","volume":"8","author":"RO Babu","year":"2012","unstructured":"Babu RO, Moorkoth D, Azeez S, Eapen SJ (2012) Virtual screening and in vitro assay of potential drug like inhibitors from spices against glutathione-S-transferase of meloidogyne incognita. Bioinformation 8(7):319\u2013325","journal-title":"Bioinformation"},{"issue":"2","key":"2733_CR38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pneurobio.2012.06.005","volume":"98","author":"KJ Doorn","year":"2012","unstructured":"Doorn KJ, Lucassen PJ, Boddeke HW, Prins M, Berendse HW, Drukarch B, van Dam AM (2012) Emerging roles of microglial activation and non-motor symptoms in Parkinson\u2019s disease. Prog Neurobiol 98(2):222\u2013238","journal-title":"Prog Neurobiol"},{"key":"2733_CR39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","volume":"6","author":"RL Mosley","year":"2006","unstructured":"Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, Laurie C, Gendelman HE (2006) Neuroinflammation, oxidative stress and the pathogenesis of Parkinson\u2019s disease. Clin Neurosci Res 6:261\u2013281","journal-title":"Clin Neurosci Res"},{"key":"2733_CR40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2015.08.044","volume":"606","author":"S Sarkar","year":"2015","unstructured":"Sarkar S, Gough B, Raymick J, Beaudoin MA, Ali SF, Virmani A, Binienda ZK (2015) Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: neuroprotective effects of acetyl-l-carnitine. Neurosci Lett 606:53\u201359","journal-title":"Neurosci Lett"},{"key":"2733_CR41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuroscience.2012.10.034","volume":"230","author":"S Swarnkar","year":"2013","unstructured":"Swarnkar S, Goswami P, Kamat PK, Patro IK, Singh S, Nath C (2013) Rotenone-induced neurotoxicity in rat brain areas: a study on neuronal and neuronal supportive cells. Neuroscience 230:172\u2013183","journal-title":"Neuroscience"},{"issue":"4","key":"2733_CR42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23(4):474\u2013483","journal-title":"Mov Disord"},{"key":"2733_CR43","first-page":"713517","volume":"2011","author":"D Littlejohn","year":"2010","unstructured":"Littlejohn D, ManFAno E, Clarke M, Bobyn J, Moloney K, Hayley S (2010) Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease. Parkinsons Dis 2011:713517","journal-title":"Parkinsons Dis"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-016-2733-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2733-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T09:04:02Z","timestamp":1600765442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-016-2733-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,17]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["2733"],"URL":"https:\/\/doi.org\/10.1007\/s11010-016-2733-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,17]]}}}